Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Total Non-Current Liabilities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Total Non-Current Liabilities for 7 consecutive years, with $17.9 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 3540.94% to $17.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.9 million through Dec 2025, up 3540.94% year-over-year, with the annual reading at $17.9 million for FY2025, 3540.94% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $17.9 million at SANUWAVE Health, down from $19.0 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $19.0 million in Q3 2025, with the low at $491000.0 in Q4 2024.
  • Average Total Non-Current Liabilities over 3 years is $3.7 million, with a median of $798500.0 recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities crashed 41.48% in 2024, then skyrocketed 3540.94% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $839000.0 in 2023, then plummeted by 41.48% to $491000.0 in 2024, then surged by 3540.94% to $17.9 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $17.9 million, $19.0 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.